Treatment options for hyperacute rejection are limited due to the rapid progression of the condition. Immediate removal of the transplanted organ may be necessary to prevent further harm to the patient. In some cases, interventions to remove or neutralize the offending antibodies, such as plasmapheresis or intravenous immunoglobulin (IVIG) therapy, may be attempted.
